About Us

Link-Medital

«Link-Medital» is a company that works on a market scince 2010. The company is engaged in the wholesale sale of high quality drugs, medical devices for the needs of medical and preventive institutions of the country.

Over
800
Patients

Read more
5
Centers

1
The biggest dialysis
Center of Ukraine

Over
15
Departments

Our Products

Fresenuis 5008S Machine

The 5008S CorDiax allows the HighVolumeHDF procedure to be performed as a standard dialysis method, thanks to the AutoSub plus function

B Brauns Dialog IQ Machine

Dialog iQ system with two biological inputs provides improved information about the patient's hemodynamic status

AquaBplus Water treatment system

AquaBplus is a basic module for permeate preparation in the dialysis center

Our Directions

Hemodialysis is one of the methods of extracorporeal blood purification (extracorporeal therapy) for patients with renal failure. Hemodialysis is a method of treating acute and chronic renal failure with the help of the device "artificial kidney".

Схема Гемадіалізу

Hemodialysis in Ukraine is receiving only about one in four people who need it, and that is about 6,000 patients. Another 35,000 Ukrainians are approaching the terminal stage of chronic renal failure and may need renal replacement therapy soon.

Link-Medital supplies quality healthcare products and medicines to a healthcare facility by a recognized German manufacturer, Fresenius.

We make every effort to ensure that as many patients with renal failure as possible receive quality and effective treatment.

Peritoneal dialysis is one of the methods of extracellular blood purification. Peritoneal dialysis uses numerous folds of the peritoneum as a filter. Dialysis fluid is introduced into the abdominal cavity with a catheter in the lower abdominal wall. A catheter is known as a dialysis catheter.

Схема Перетонеального Діалізу

Peritoneal dialysis eliminates metabolic products when the kidneys are not functioning properly, as well as toxic substances such as excess endogenous fluids that are released by the kidneys if their functioning is normal. In addition, peritoneal dialysis helps correct electrolyte imbalances to reduce swelling.

Link-Medital supplies quality healthcare products and medicines to recognized healthcare providers from the renowned German manufacturer Fresenius.

We make every effort to ensure that as many patients with renal failure as possible receive quality and effective treatment.

Hemophilia is a genetic disease caused by congenital blood coagulation factor protein deficiency. Mainly for the prevention of hemophilia used substitution therapy - the regular introduction of drugs containing the missing protein - a factor in blood clotting.

Link-Medital supplies the highest blood clotting factors for the healthcare industry to companies named Baxter. The most famous drugs - Immunate, Immune, Recombinate, Feiba - anti-inhibitory coagulant complex.

In addition to blood factors, Link-Medital provides healthcare facilities and other immunobiological preparations - human normal immunoglobulin, human albumin and more.

The company, for its part, always makes every effort to ensure that Ukrainian patients receive high-quality immunobiological preparations on time, with strict compliance with the requirements for safety and quality of products.

Orphan diseases are rare congenital or acquired diseases that are characterized by a severe, chronic, progressive course, accompanied by the formation of degenerative changes in the body, decreased quality and shortened life expectancy of patients, and even pose a threat to their lives. People with Orphan Diseases usually require costly, continuous, and lifelong treatment. Most orphan diseases are diagnosed at an early age, in 35 % of cases they cause infant death by the year, in 10 % - children under 5 years of age, in 12 % - in the age of 5 to 15 years.

In view of the patients' needs, Link-Medital is making every effort to develop this area by planning to provide healthcare facilities with the highest quality medicines, including for the treatment of primary immunodeficiencies, Anderson-Fabry disease, mucopolysaccharidosis, juvenile rheumatoid arthritis.

Latest News

Our Partners